{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:51:47Z","timestamp":1790290307884,"version":"4.1.0"},"reference-count":71,"publisher":"Radcliffe Medical Media Ltd","license":[{"start":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T00:00:00Z","timestamp":1638835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Cardiol"],"abstract":"<jats:p>Aortic valve stenosis (AS) is the most common valvular heart disease among elderly patients. Since the pathophysiology of degenerative AS shares common pathways with atherosclerotic disease, the severity of AS in the elderly population is often concurrent to the presence of coronary artery disease (CAD). Although surgical aortic valve replacement has been the standard treatment for severe AS, the high operative morbidity and mortality in complex and fragile patients was the trigger to develop less invasive techniques. Transcatheter aortic valve implantation (TAVI) has been posed as the standard of care for elderly patients with severe AS with various risk profiles, which has meant that the concomitant management of CAD has become a crucial issue in such patients. Given the lack of randomised controlled trials evaluating the management of CAD in TAVI patients, most of the recommendations are based on retrospective cohort studies so that the Heart Team approach \u2013 together with an assessment of multiple parameters including symptoms and clinical characteristics, invasive and non-invasive ischaemic burden and anatomy \u2013 are crucial for the proper management of these patients. This article provides a review of current knowledge about assessment and therapeutic approaches for CAD and severe AS in patients undergoing TAVI.<\/jats:p>","DOI":"10.15420\/ecr.2021.27","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T18:11:19Z","timestamp":1638900679000},"source":"Crossref","is-referenced-by-count":20,"title":["Coronary Artery Disease in Patients with Aortic Stenosis and Transcatheter Aortic Valve Implantation: Implications for Management"],"prefix":"10.15420","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3202-5360","authenticated-orcid":false,"given":"Antonio FB","family":"de Azevedo Filho","sequence":"first","affiliation":[{"name":"Department of Valvular Heart Disease, Heart Institute (InCor), S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8023-3466","authenticated-orcid":false,"given":"Tarso AD","family":"Accorsi","sequence":"additional","affiliation":[{"name":"Department of Valvular Heart Disease, Heart Institute (InCor), S\u00e3o Paulo, Brazil; Samaritano Paulista Hospital, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1273-1823","authenticated-orcid":false,"given":"Henrique B","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Samaritano Paulista Hospital, S\u00e3o Paulo, Brazil; Interventional Cardiology Department, Heart Institute (InCor), S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6096","published-online":{"date-parts":[[2021,12,7]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Pibarot P, Dumesnil JG. Improving assessment of aortic stenosis. J Am Coll Cardiol 2012;60:169\u201380. https:\/\/doi.org\/10.1016\/j.jacc.2011.11.078; PMID:\u00a022789881.","DOI":"10.1016\/j.jacc.2011.11.078"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997;29:630\u20134. https:\/\/doi.org\/10.1016\/S0735-1097(96)00563-3; PMID:\u00a09060903.","DOI":"10.1016\/S0735-1097(96)00563-3"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Thalji NM, Suri RM, Daly RC, et al. Assessment of coronary artery disease risk in 5463 patients undergoing cardiac surgery: when is preoperative coronary angiography necessary? J Thorac Cardiovasc Surg 2013;146:1055\u201363. https:\/\/doi.org\/10.1016\/j.jtcvs.2013.06.046; PMID:\u00a024012061.","DOI":"10.1016\/j.jtcvs.2013.06.046"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Malmberg M, Gunn J, Sipila J, et al. Comparison of long-term outcomes of patients having surgical aortic valve replacement with versus without simultaneous coronary artery bypass grafting. Am J Cardiol 2020;125:964\u20139. https:\/\/doi.org\/10.1016\/j.amjcard.2019.12.015; PMID:\u00a031948663.","DOI":"10.1016\/j.amjcard.2019.12.015"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Lerman DA, Prasad S, Alotti N. Calcific aortic valve disease: molecular mechanisms and therapeutic approaches. Eur Cardiol 2015;10:108\u201312. https:\/\/doi.org\/10.15420\/ecr.2015.10.2.108; PMID:\u00a027274771.","DOI":"10.15420\/ecr.2015.10.2.108"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Yang Y, Huang FY, Huang BT, et al. The safety of concomitant transcatheter aortic valve replacement and percutaneous coronary intervention: a systematic review and meta-analysis. Medicine (Baltimore) 2017;96:e8919. https:\/\/doi.org\/10.1097\/MD.0000000000008919; PMID:\u00a029310382.","DOI":"10.1097\/md.0000000000008919"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Kotronias RA, Kwok CS, George S, et al. Transcatheter aortic valve implantation with or without percutaneous coronary artery revascularization strategy: a systematic review and meta-analysis. J Am Heart Assoc 2017;6 e005960. https:\/\/doi.org\/10.1161\/JAHA.117.005960; PMID:\u00a028655733.","DOI":"10.1161\/jaha.117.005960"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"D\u2019Ascenzo F, Verardi R, Visconti M, et al. Independent impact of extent of coronary artery disease and percutaneous revascularisation on 30-day and one-year mortality after TAVI: a meta-analysis of adjusted observational results. EuroIntervention 2018;14:e1169\u201377. https:\/\/doi.org\/10.4244\/EIJ-D-18-00098; PMID:\u00a030082258.","DOI":"10.4244\/eij-d-18-00098"},{"key":"ref8","unstructured":"Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 2019;380:1695\u2013705. https:\/\/doi.org\/10.1056\/NEJMoa1814052; PMID:\u00a030883058."},{"key":"ref9","unstructured":"Makkar RR, Thourani VH, Mack MJ, et al. Five-year outcomes of transcatheter or surgical aortic-valve replacement. N Engl J Med 2020;382:799\u2013809. https:\/\/doi.org\/10.1056\/NEJMoa1910555; PMID:\u00a031995682."},{"key":"ref10","unstructured":"Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med 2019;380:1706\u201315. https:\/\/doi.org\/10.1056\/NEJMoa1816885; PMID:\u00a030883053."},{"key":"ref11","unstructured":"Popma JJ, Adams DH, Reardon MJ, et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol 2014;63:1972\u201381. https:\/\/doi.org\/10.1016\/j.jacc.2014.02.556; PMID:\u00a024657695."},{"key":"ref12","unstructured":"Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med 2017;376:1321\u201331. https:\/\/doi.org\/10.1056\/NEJMoa1700456; PMID:\u00a028304219."},{"key":"ref13","unstructured":"Sengupta A, Zaid S, Kamioka N, et al. Mid-term outcomes of transcatheter aortic valve replacement in extremely large annuli with Edwards SAPIEN 3 valve. JACC Cardiovasc Interv 2020;13:210\u20136. https:\/\/doi.org\/10.1016\/j.jcin.2019.08.042; PMID:\u00a031883715."},{"key":"ref14","unstructured":"Van Mieghem NM, Popma JJ, Deeb GM, et al. Complete 2-year results confirm Bayesian analysis of the SURTAVI trial. JACC Cardiovasc Interv 2020;13:323\u201331. https:\/\/doi.org\/10.1016\/j.jcin.2019.10.043; PMID:\u00a032029248."},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Sankaramangalam K, Banerjee K, Kandregula K, et al. Impact of coronary artery disease on 30-day and 1-year mortality in patients undergoing transcatheter aortic valve replacement: a meta-analysis. J Am Heart Assoc 2017;6:e006092. https:\/\/doi.org\/10.1161\/JAHA.117.006092; PMID:\u00a029021275.","DOI":"10.1161\/jaha.117.006092"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Faroux L, Guimaraes L, Wintzer-Wehekind J, et al. Coronary artery disease and transcatheter aortic valve replacement: JACC state-of-the-art review. J Am Coll Cardiol 2019;74:362\u201372. https:\/\/doi.org\/10.1016\/j.jacc.2019.06.012; PMID:\u00a031319919.","DOI":"10.1016\/j.jacc.2019.06.012"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Fihn SD, Blankenship JC, Alexander KP, et al. 2014 ACC\/AHA\/AATS\/PCNA\/SCAI\/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2014;64:1929\u201349. https:\/\/doi.org\/10.1016\/j.jacc.2014.07.017; PMID:\u00a025077860.","DOI":"10.1161\/CIR.0000000000000095"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC\/EACTS Guidelines on myocardial revascularization. Eur Heart J 2019;40:87\u2013165. https:\/\/doi.org\/10.1093\/eurheartj\/ehy394; PMID:\u00a030165437.","DOI":"10.1093\/eurheartj\/ehy855"},{"key":"ref19","unstructured":"Ahmad Y, Gotberg M, Cook C, et al. Coronary hemodynamics in patients with severe aortic stenosis and coronary artery disease undergoing transcatheter aortic valve replacement: implications for clinical indices of coronary stenosis severity. JACC Cardiovasc Interv 2018;11:2019\u201331. https:\/\/doi.org\/10.1016\/j.jcin.2018.07.019; PMID:\u00a030154062."},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Pesarini G, Scarsini R, Zivelonghi C, et al. Functional assessment of coronary artery disease in patients undergoing transcatheter aortic valve implantation: influence of pressure overload on the evaluation of lesions severity. Circ Cardiovasc Interv 2016;9:e004088. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.116.004088; PMID:\u00a027803040.","DOI":"10.1161\/circinterventions.116.004088"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Scarsini R, Pesarini G, Lunardi M, et al. Observations from a real-time, iFR-FFR \u2018hybrid approach\u2019 in patients with severe aortic stenosis and coronary artery disease undergoing TAVI. Cardiovasc Revasc Med 2018;19:355\u20139. https:\/\/doi.org\/10.1016\/j.carrev.2017.09.019; PMID:\u00a029113864.","DOI":"10.1016\/j.carrev.2017.09.019"},{"key":"ref22","unstructured":"Stanojevic D, Gunasekaran P, Tadros P, et al. Intravenous adenosine infusion is safe and well tolerated during coronary fractional flow reserve assessment in elderly patients with severe aortic stenosis. J Invasive Cardiol 2016;28:357\u201361. PMID:\u00a027315577."},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Lunardi M, Scarsini R, Venturi G, et al. Physiological versus angiographic guidance for myocardial revascularization in patients undergoing transcatheter aortic valve implantation. J Am Heart Assoc 2019;8:e012618. https:\/\/doi.org\/10.1161\/JAHA.119.012618; PMID:\u00a031718439.","DOI":"10.1161\/jaha.119.012618"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Gotberg M, Cook CM, Sen S, et al. The evolving future of instantaneous wave-free ratio and fractional flow reserve. J Am Coll Cardiol 2017;70:1379\u2013402. https:\/\/doi.org\/10.1016\/j.jacc.2017.07.770; PMID:\u00a028882237.","DOI":"10.1016\/j.jacc.2017.07.770"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Andreini D, Pontone G, Mushtaq S, et al. Diagnostic accuracy of multidetector computed tomography coronary angiography in 325 consecutive patients referred for transcatheter aortic valve replacement. Am Heart J 2014;168:332\u20139. https:\/\/doi.org\/10.1016\/j.ahj.2014.04.022; PMID:\u00a025173545.","DOI":"10.1016\/j.ahj.2014.04.022"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Hamdan A, Wellnhofer E, Konen E, et al. Coronary CT angiography for the detection of coronary artery stenosis in patients referred for transcatheter aortic valve replacement. J Cardiovasc Comput Tomogr 2015;9:31\u201341. https:\/\/doi.org\/10.1016\/j.jcct.2014.11.008; PMID:\u00a025576406.","DOI":"10.1016\/j.jcct.2014.11.008"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Harris BS, De Cecco CN, Schoepf UJ, et al. Dual-source CT imaging to plan transcatheter aortic valve replacement: accuracy for diagnosis of obstructive coronary artery disease. Radiology 2015;275:80\u20138. https:\/\/doi.org\/10.1148\/radiol.14140763; PMID:\u00a025393848.","DOI":"10.1148\/radiol.14140763"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Matsumoto S, Yamada Y, Hashimoto M, et al. CT imaging before transcatheter aortic valve implantation (TAVI) using variable helical pitch scanning and its diagnostic performance for coronary artery disease. Eur Radiol 2017;27:1963\u201370. https:\/\/doi.org\/10.1007\/s00330-016-4547-4; PMID:\u00a027562479.","DOI":"10.1007\/s00330-016-4547-4"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Meier D, Depierre A, Topolsky A, et al. Computed tomography angiography for the diagnosis of coronary artery disease among patients undergoing transcatheter aortic valve implantation. J Cardiovasc Transl Res 2021. https:\/\/doi.org\/10.1007\/s12265-021-10099-8; PMID:\u00a033543417; epub ahead of press.","DOI":"10.1007\/s12265-021-10099-8"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Opolski MP, Kim WK, Liebetrau C, et al. Diagnostic accuracy of computed tomography angiography for the detection of coronary artery disease in patients referred for transcatheter aortic valve implantation. Clin Res Cardiol 2015;104:471\u201380. https:\/\/doi.org\/10.1007\/s00392-014-0806-z; PMID:\u00a025559245.","DOI":"10.1007\/s00392-014-0806-z"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Pontone G, Andreini D, Bartorelli AL, et al. Feasibility and accuracy of a comprehensive multidetector computed tomography acquisition for patients referred for balloon-expandable transcatheter aortic valve implantation. Am Heart J 2011;161:1106\u201313. https:\/\/doi.org\/10.1016\/j.ahj.2011.03.003; PMID:\u00a021641357.","DOI":"10.1016\/j.ahj.2011.03.003"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Strong C, Ferreira A, Teles RC, et al. Diagnostic accuracy of computed tomography angiography for the exclusion of coronary artery disease in candidates for transcatheter aortic valve implantation. Sci Rep 2019;9:19942. https:\/\/doi.org\/10.1038\/s41598-019-56519-3; PMID:\u00a031882777.","DOI":"10.1038\/s41598-019-56519-3"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Chieffo A, Giustino G, Spagnolo P, et al. Routine screening of coronary artery disease with computed tomographic coronary angiography in place of invasive coronary angiography in patients undergoing transcatheter aortic valve replacement. Circ Cardiovasc Interv 2015;8:e002025. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.114.002025; PMID:\u00a026160830.","DOI":"10.1161\/circinterventions.114.002025"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"van den Boogert TPW, Vendrik J, Claessen B, et al. CTCA for detection of significant coronary artery disease in routine TAVI work-up: a systematic review and meta-analysis. Neth Heart J 2018;26:591\u20139. https:\/\/doi.org\/10.1007\/s12471-018-1149-6; PMID:\u00a030178209.","DOI":"10.1007\/s12471-018-1149-6"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"van den Boogert TPW, Claessen B, Opolski MP, et al. DEtection of ProxImal Coronary stenosis in the work-up for Transcatheter aortic valve implantation using CTA (from the DEPICT CTA collaboration). Eur Radiol 2021. https:\/\/doi.org\/10.1007\/s00330-021-08095-2; PMID:\u00a034132873; epub ahead of press.","DOI":"10.1007\/s00330-021-08095-2"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Lu MT, Ferencik M, Roberts RS, et al. Noninvasive FFR derived from coronary CT angiography: management and outcomes in the PROMISE trial. JACC Cardiovasc Imaging 2017;10:1350\u20138. https:\/\/doi.org\/10.1016\/j.jcmg.2016.11.024; PMID:\u00a028412436.","DOI":"10.1016\/j.jcmg.2016.11.024"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Michail M, Ihdayhid AR, Comella A, et al. Feasibility and validity of computed tomography-derived fractional flow reserve in patients with severe aortic stenosis: The CAST-FFR study. Circ Cardiovasc Interv 2021;14:e009586. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.120.009586; PMID:\u00a033322917.","DOI":"10.1161\/circinterventions.120.009586"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Mejia-Renteria H, Lee JM, Lauri F, et al. Influence of microcirculatory dysfunction on angiography-based functional assessment of coronary stenoses. JACC Cardiovasc Interv 2018;11:741\u201353. https:\/\/doi.org\/10.1016\/j.jcin.2018.02.014; PMID:\u00a029673505.","DOI":"10.1016\/j.jcin.2018.02.014"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Mejia-Renteria H, Nombela-Franco L, Paradis JM, et al. Angiography-based quantitative flow ratio versus fractional flow reserve in patients with coronary artery disease and severe aortic stenosis. EuroIntervention 2020;16:e285\u201392. https:\/\/doi.org\/10.4244\/EIJ-D-19-01001; PMID:\u00a032207408.","DOI":"10.4244\/eij-d-19-01001"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Ramee S, Anwaruddin S, Kumar G, et al. The rationale for performance of coronary angiography and stenting before transcatheter aortic valve replacement: from the Interventional Section Leadership Council of the American College of Cardiology. JACC Cardiovasc Interv 2016;9:2371\u20135. https:\/\/doi.org\/10.1016\/j.jcin.2016.09.024; PMID:\u00a027931592.","DOI":"10.1016\/j.jcin.2016.09.024"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Khawaja MZ, Wang D, Pocock S, et al. The percutaneous coronary intervention prior to transcatheter aortic valve implantation (ACTIVATION) trial: study protocol for a randomized controlled trial. Trials 2014;15:300. https:\/\/doi.org\/10.1186\/1745-6215-15-300; PMID:\u00a025059340.","DOI":"10.1186\/1745-6215-15-300"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Patterson T, Clayton T, Dodd M, et al. ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): a randomized clinical trial. JACC Cardiovasc Interv 2021;14:1965\u201374. https:\/\/doi.org\/10.1016\/j.jcin.2021.06.041; PMID:\u00a034556269.","DOI":"10.1016\/j.jcin.2021.06.041"},{"key":"ref43","unstructured":"Chakravarty T, Sharma R, Abramowitz Y, et al. Outcomes in patients with transcatheter aortic valve replacement and left main stenting: the TAVR-LM registry. J Am Coll Cardiol 2016;67:951\u201360. https:\/\/doi.org\/10.1016\/j.jacc.2015.10.103; PMID:\u00a026916485."},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Witberg G, Zusman O, Codner P, et al. Impact of coronary artery revascularization completeness on outcomes of patients with coronary artery disease undergoing transcatheter aortic valve replacement: a meta-analysis of studies using the residual SYNTAX score (synergy between PCI with taxus and cardiac surgery). Circ Cardiovasc Interv 2018;11:e006000. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.117.006000; PMID:\u00a029870384.","DOI":"10.1161\/circinterventions.117.006000"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Paradis JM, Fried J, Nazif T, et al. Aortic stenosis and coronary artery disease: what do we know? What don\u2019t we know? A comprehensive review of the literature with proposed treatment algorithms. Eur Heart J 2014;35:2069\u201382. https:\/\/doi.org\/10.1093\/eurheartj\/ehu247; PMID:\u00a024970334.","DOI":"10.1093\/eurheartj\/ehu247"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"van Rosendael PJ, van der Kley F, Kamperidis V, et al. Timing of staged percutaneous coronary intervention before transcatheter aortic valve implantation. Am J Cardiol 2015;115:1726\u201332. https:\/\/doi.org\/10.1016\/j.amjcard.2015.03.019; PMID:\u00a025890631.","DOI":"10.1016\/j.amjcard.2015.03.019"},{"key":"ref47","unstructured":"Allende R, Webb JG, Munoz-Garcia AJ, et al. Advanced chronic kidney disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes and prognostic markers from a large cohort of patients. Eur Heart J 2014;35:2685\u201396. https:\/\/doi.org\/10.1093\/eurheartj\/ehu175; PMID:\u00a024796337."},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Perez S, Thielhelm TP, Cohen MG. To revascularize or not before transcatheter aortic valve implantation? J Thorac Dis 2018;10:s3578\u2013S87. https:\/\/doi.org\/10.21037\/jtd.2018.09.85; PMID:\u00a030505538.","DOI":"10.21037\/jtd.2018.09.85"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Barbanti M, Todaro D, Costa G, et al. Optimized screening of coronary artery disease with invasive coronary angiography and ad hoc percutaneous coronary intervention during transcatheter aortic valve replacement. Circ Cardiovasc Interv 2017;10:e005234. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.117.005234; PMID:\u00a028768757.","DOI":"10.1161\/circinterventions.117.005234"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Penkalla A, Pasic M, Drews T, et al. Transcatheter aortic valve implantation combined with elective coronary artery stenting: a simultaneous approach. Eur J Cardiothorac Surg 2015;47:1083\u20139. https:\/\/doi.org\/10.1093\/ejcts\/ezu339; PMID:\u00a025217500.","DOI":"10.1093\/ejcts\/ezu339"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Ochiai T, Yoon SH, Flint N, et al. Timing and outcomes of percutaneous coronary intervention in patients who underwent transcatheter aortic valve implantation. Am J Cardiol 2020;125:1361\u20138. https:\/\/doi.org\/10.1016\/j.amjcard.2020.01.043; PMID:\u00a032106928.","DOI":"10.1016\/j.amjcard.2020.01.043"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Blumenstein J, Kim WK, Liebetrau C, et al. Challenges of coronary angiography and intervention in patients previously treated by TAVI. Clin Res Cardiol 2015;104:632\u20139. https:\/\/doi.org\/10.1007\/s00392-015-0824-5; PMID:\u00a025720330.","DOI":"10.1007\/s00392-015-0824-5"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Nai Fovino L, Scotti A, Massussi M, et al. Coronary angiography after transcatheter aortic valve replacement (TAVR) to evaluate the risk of coronary access impairment after TAVR-in-TAVR. J Am Heart Assoc 2020;9:e016446. https:\/\/doi.org\/10.1161\/JAHA.120.016446; PMID:\u00a032578484.","DOI":"10.1161\/jaha.120.016446"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Ten Berg J, Sibbing D, Rocca B, et al. Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart Disease. Eur Heart J 2021;42:2265\u20139. https:\/\/doi.org\/10.1093\/eurheartj\/ehab196; PMID:\u00a033822924.","DOI":"10.1093\/eurheartj\/ehab196"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Redondo A, Valencia-Serrano F, Santos-Martinez S, et al. Accurate commissural alignment during ACURATE neo TAVI procedure. Proof of concept. Rev Esp Cardiol (Engl Ed) 2021. https:\/\/doi.org\/10.1016\/j.rec.2021.02.004; PMID:\u00a033781722; epub ahead of press.","DOI":"10.1016\/j.rec.2021.02.004"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Yudi MB, Sharma SK, Tang GHL, Kini A. Coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement. J Am Coll Cardiol 2018;71:1360\u201378. https:\/\/doi.org\/10.1016\/j.jacc.2018.01.057; PMID:\u00a029566822.","DOI":"10.1016\/j.jacc.2018.01.057"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Ribeiro HB, Nombela-Franco L, Urena M, et al. Coronary obstruction following transcatheter aortic valve implantation: a systematic review. JACC Cardiovasc Interv 2013;6:452\u201361. https:\/\/doi.org\/10.1016\/j.jcin.2012.11.014; PMID:\u00a023602458.","DOI":"10.1016\/j.jcin.2012.11.014"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Ribeiro HB, Rodes-Cabau J, Blanke P, et al. Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry. Eur Heart J 2018;39:687\u201395. https:\/\/doi.org\/10.1093\/eurheartj\/ehx455; PMID:\u00a029020413.","DOI":"10.1093\/eurheartj\/ehx455"},{"key":"ref59","unstructured":"Ribeiro HB, Webb JG, Makkar RR, et al. Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry. J Am Coll Cardiol 2013;62:1552\u201362. https:\/\/doi.org\/10.1016\/j.jacc.2013.07.040; PMID:\u00a023954337."},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Stefanini GG, Cerrato E, Pivato CA, et al. Unplanned percutaneous coronary revascularization after TAVR: a multicenter international registry. JACC Cardiovasc Interv 2021;14:198\u2013207. https:\/\/doi.org\/10.1016\/j.jcin.2020.10.031; PMID:\u00a033478637.","DOI":"10.1016\/j.jcin.2020.10.031"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Vilalta V, Asmarats L, Ferreira-Neto AN, et al. Incidence, clinical characteristics, and impact of acute coronary syndrome following transcatheter aortic valve replacement. JACC Cardiovasc Interv 2018;11:2523\u201333. https:\/\/doi.org\/10.1016\/j.jcin.2018.09.001; PMID:\u00a030573061.","DOI":"10.1016\/j.jcin.2018.09.001"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"Lugomirski P, McArdle B, Alak A, et al. Late presentation of left main coronary artery impingement post-transcatheter aortic valve replacement. JACC Cardiovasc Interv 2015;8:e159\u201360. https:\/\/doi.org\/10.1016\/j.jcin.2015.03.033; PMID:\u00a026315749.","DOI":"10.1016\/j.jcin.2015.03.033"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"Ramirez R, Ovakimyan O, Lasam G, Lafferty K. A very late presentation of a right coronary artery occlusion after transcatheter aortic valve replacement. Cardiol Res 2017;8:131\u20133. https:\/\/doi.org\/10.14740\/cr559w; PMID:\u00a028725331.","DOI":"10.14740\/cr559w"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"Soufras GD, Hahalis G, Kounis NG. Thrombotic complications associated with transcatheter aortic valve implantation: the role of Kounis hypersensitivity-associated thrombotic syndrome. Cardiovasc Pathol 2014;23:383\u20134. https:\/\/doi.org\/10.1016\/j.carpath.2014.06.004; PMID:\u00a025060387.","DOI":"10.1016\/j.carpath.2014.06.004"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"Rodes-Cabau J, Masson JB, Welsh RC, et al. Aspirin versus aspirin plus clopidogrel as antithrombotic treatment following transcatheter aortic valve replacement with a balloon-expandable valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) randomized clinical trial. JACC Cardiovasc Interv 2017;10:1357\u201365. https:\/\/doi.org\/10.1016\/j.jcin.2017.04.014; PMID:\u00a028527771.","DOI":"10.1016\/j.jcin.2017.04.014"},{"key":"ref66","unstructured":"Brouwer J, Nijenhuis VJ, Delewi R, et al. Aspirin with or without clopidogrel after transcatheter aortic-valve implantation. N Engl J Med 2020;383:1447\u201357. https:\/\/doi.org\/10.1056\/NEJMoa2017815; PMID:\u00a032865376."},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021;143:e72\u2013227. https:\/\/doi.org\/10.1161\/CIR.0000000000000932; PMID:\u00a033332149.","DOI":"10.1161\/cir.0000000000000932"},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"Tarantini G, Mojoli M, Windecker S, et al. Prevalence and impact of atrial fibrillation in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis from the SOURCE XT prospective multicenter registry. JACC Cardiovasc Interv 2016;9:937\u201346. https:\/\/doi.org\/10.1016\/j.jcin.2016.01.037; PMID:\u00a027085579.","DOI":"10.1016\/j.jcin.2016.01.037"},{"key":"ref69","unstructured":"Valgimigli M, Bueno H, Byrne RA, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2018;39:213\u201360. https:\/\/doi.org\/10.1093\/eurheartj\/ehx419; PMID:\u00a028886622."},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"Kuno T, Yokoyama Y, Briasoulis A, et al. Duration of antiplatelet therapy following transcatheter aortic valve replacement: systematic review and network meta-analysis. J Am Heart Assoc 2021;10:e019490. https:\/\/doi.org\/10.1161\/JAHA.120.019490; PMID:\u00a033870703.","DOI":"10.1161\/jaha.120.019490"}],"container-title":["European Cardiology Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ecrjournal.com\/articleindex\/ecr.2021.27","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T18:11:30Z","timestamp":1638900690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ecrjournal.com\/articleindex\/ecr.2021.27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,7]]},"references-count":71,"URL":"https:\/\/doi.org\/10.15420\/ecr.2021.27","relation":{},"ISSN":["1758-3764","1758-3756"],"issn-type":[{"value":"1758-3764","type":"electronic"},{"value":"1758-3756","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,7]]},"article-number":"e49"}}